The proliferation of wearable devices is giving physicians some pause about the usability of the data they collect, reports NPR.

Although reports so far on Meaningful Use Stage progress appear bleak, federal health officials counter that the majority of providers eligible to attest to MU Stage 2 already have done so, reports Clinical Innovation + Technology. 

Federal Trade Commission Chair Edith Ramirez is calling on IT companies that manufacture medical devices to put the necessary safeguards in place to protect patient data, according to MEDCITY News.

Pharmaceutical company Genetech is expected to pay as much as $50 million to 23andMe to access its genetic data donated by consumers, reports The Verge.

The Department of Defense has yet to choose which bidder will take on its $11 EHR billion contract, but that has not stopped IBM and Epic from beginning preparations on their collaborative effort to overhaul the system, reports FCW.

Big news on the Meaningful Use Stage 3 front: The proposed rule has been sent to the Office of Management and Budget and will be published in the Federal Register upon review, reports Clinical Innovation + Technology.

The vast majority of states and the federal government fail to track how many Medicaid physicians use EHRs, reports Politico. 

Apple iOS 8/2, which was released in beta form to developers last week, contains notes indicating that blood glucose tracking will be included as a feature, reports Forbes.